Select Equity Group
CLBT icon

Select Equity Group’s Cellebrite CLBT Stock Holding History

Select Equity Group’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.1M Buy
1,105,877
+301,484
+37% +$3.98M 0.08% 122
2026
Q1 		$11.1M Buy
804,393
+184,251
+30% +$2.78M 0.06% 137
2025
Q4 		$11.2M Sell
620,142
-46,508
-7% -$835K 0.05% 142
2025
Q3 		$12.4M Buy
666,650
+319,284
+92% +$5.02M 0.05% 127
2025
Q2 		$5.56M Buy
+347,366
New +$6.19M 0.02% 137

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Select Equity Group's CLBT Position: Q2 2026 in Review

Select Equity Group increased its Cellebrite (CLBT) stake by 37% in Q2 2026, buying an estimated $3.98M and bringing the position to 1,105,877 shares worth $16.1M. The position accounts for 0.08% of the portfolio, ranked #122.

Select Equity Group first reported a position in CLBT in Q2 2025 and has held it in 5 quarters since. 200 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Select Equity Group held 1,105,877 shares of Cellebrite worth $16.1M as of Q2 2026.
  • Select Equity Group bought 301,484 Cellebrite shares in Q2 2026, an estimated $3.98M.
  • Cellebrite made up 0.08% of Select Equity Group's portfolio in Q2 2026, its #122 holding.
  • Select Equity Group first reported a position in Cellebrite in Q2 2025 and has held it in 5 quarters since.
  • 200 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Select Equity Group's 13F filing for Q2 2026, filed 14 Aug 2026.